APA (7th ed.) Citation

Corcoran, C., Rani, S., Breslin, S., Gogarty, M., Ghobrial, I. M., Crown, J., & O’Driscoll, L. Correction: MiR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. BMC.

Chicago Style (17th ed.) Citation

Corcoran, Claire, Sweta Rani, Susan Breslin, Martina Gogarty, Irene M. Ghobrial, John Crown, and Lorraine O’Driscoll. Correction: MiR-630 Targets IGF1R to Regulate Response to HER-targeting Drugs and Overall Cancer Cell Progression in HER2 Over-expressing Breast Cancer. BMC.

MLA (9th ed.) Citation

Corcoran, Claire, et al. Correction: MiR-630 Targets IGF1R to Regulate Response to HER-targeting Drugs and Overall Cancer Cell Progression in HER2 Over-expressing Breast Cancer. BMC.